The Latest
-
Getty Images
Zimmer CEO ‘very surprised’ by Q3 sales miss
CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall.
-
sturti via Getty Images
Sponsored by IQVIA MedTechDesigning smarter trials for new devices: 3 best practices for developers
Discover three strategies for MedTech companies to design streamlined, effective trials and how quality data powers smarter study design.
-
Courtesy of Qiagen
Qiagen inks $225M single-cell buyout as CEO prepares to step down
Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.
-
Permission granted by Aspen Institute
Legislators object to proposed CMS payment changes for diabetes tech
In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce access to glucose monitors and insulin pumps.
-
Courtesy of Dexcom
Dexcom recalls G6 CGM app over software problem
A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download an update.
-
Al Drago via Getty Images
Health groups urge passage of bill to ease Medicare pay cuts for tests
More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent legislative solution to stop looming Medicare payment cuts for diagnostic tests.
-
Getty Images
Olympus further clarifies device use after serious injuries and death
The update is intended to cut the risk of endobronchial combustion that has been linked to serious injuries and one death.
-
Courtesy of Edwards Lifesciences
Edwards CFO Scott Ullem to exit post
Ullem, who has held the position for more than a decade, will transition to an advisory role after his replacement is named by mid-2026.
-
Alamy
Dexcom execs say company has fixed G7 quality problems
After dealing with a deployment issue with glucose monitors earlier this year, interim CEO Jake Leach said improving customer service has also been a focus for the company.
-
Permission granted by Agilent
Agilent selects Adam Elinoff as CFO
The appointment fills a position made available when Bob McMahon resigned as CFO on July 31.
-
Courtesy of Philips
3 takeaways from TCT 2025
Trials from Edwards, Philips and Penumbra were among the most-watched studies at the annual cardiovascular meeting.
-
Patrik Stollarz / Staff via Getty Images
Philips receives FDA warning letter over quality issues
The notice follows inspections of three Philips facilities that found failures to meet standards for reporting complaints and corrective actions.
-
Andrew Harnik via Getty Images
US to lower China tariffs as part of trade war truce
The truce also includes de-escalating other trade actions, such as China's rare earth export controls and U.S. investigations into China-linked ships.
-
Courtesy of Medline
Medline files for initial public offering
The medical and surgical products provider could reportedly raise $5 billion at a $50 billion valuation.
-
Permission granted by Medtronic
CMS grants NCD for renal denervation, benefiting Medtronic, Recor
National Medicare coverage paves the way for a larger patient population to access the blood pressure treatment, which gained FDA approval in 2023.
-
Getty Images
Zimmer wins FDA’s breakthrough status for tech to prevent joint infections
Integrating a controlled-release iodine layer into hip implants could reduce the rate of potentially fatal infections.
-
Courtesy of Thermo Fisher Scientific
Thermo Fisher to acquire clinical trial data firm Clario for $8.9B
The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more trials.
-
Courtesy of Johnson & Johnson
J&J partners with Nvidia on AI for kidney stone procedures
The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.
-
Courtesy of Olympus
Olympus execs talk about import alert, GI robot and AI
CEO Bob White and Chief Strategy Officer Gabriela Kaynor discussed the medtech company’s quality and technology priorities after a year of change.
-
Courtesy of Medtronic
Medtronic links renal denervation to 3-year blood pressure reduction
Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.
-
Courtesy of CardioPrecision
ProfileCorcym, CardioPrecision set sights on robotic heart valve replacement
The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.
-
Emily Olsen/MedTech Dive
Deep DiveHealth systems are racing to adopt AI. But can they prove its value?
Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, like provider and patient satisfaction, are important too — and also impact providers’ bottom lines.
-
Mario Tama via Getty Images
J&J awards first grants from AI surgery fund
Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.
-
Getty Images
CMS calls back furloughed employees to help with Medicare, ACA enrollment periods
Roughly 3,000 employees are coming back to work on Monday, funded by user fees as the shutdown drags into its fourth week.
-
Justin Sullivan via Getty Images
Medtech industry closely watching Section 232 investigation
The investigation, which could be used to impose tariffs for medical products, has raised the attention of several industry groups. Check out MedTech Dive’s roundup of coverage on the 232 probe.
-
Permission granted by Accuray
Accuray hires Steve La Neve as CEO in transformation effort
The radiotherapy systems maker unveiled the leadership change and strategy initiatives as it reported a preliminary fiscal first-quarter adjusted loss.
